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Persuasive adverts and exaggeration of health benefits from consumption of herbal products as well 
as the mental picture of ‘natural’ is ‘safe’ has boosted traditional medicine use in Uganda. However, 
herbal products may be unsafe due to the possibility of their contamination with mycotoxins. In this 
study, we quantified the levels of aflatoxins (B1, B2, G1 and G2) in Real Koff product, Eddagala ly’e 
kifuba n’e senyiga, Omusujja, Cough mixture and Fever herbal products sold in Kampala, Uganda 
using high performance liquid chromatography-tandem mass spectrometry. The associated 
consumption health risks were assessed using the hazard index method. Only aflatoxin B1 was 
detected in 60% of the samples, with 40% of these surpassing WHO guidelines of ≤ 5 µg/kg. The 
hazard indices were all less than 1, implying that Ugandans who heavily rely on the herbal products 
are exposed to aflatoxins at sublethal doses which may lead to chronic effects in the long run. Studies 
using a larger sample size should assess whether the current observation is a routine occurrence or a 
sporadic event.    
________________________________________________________________________________ 
Introduction 
Plants have been known for their medicinal 
potential since antiquity [1]. They continue to be 
a veritable source of not less than 40% of the 
current therapeutically utilized products. Some 
studies have indicated that the use of herbal 
products to address health challenges could be 
unsafe due to the possibility of their 
contamination with heavy metals [2, 3], pesticide 
residues, and toxigenic fungi such as Aspergillus, 
Fusarium and Penicillium species during 
processing and packaging [4, 5]. These fungi are 
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known to produce potential mycotoxins 
(aflatoxins, fumonisins, ochratoxins, 
deoxynivalenol, zearalenone and T-2 toxins), 
which may have negative health impacts on 
humans [6].  
 Aflatoxins (AFs) is a group of secondary 
metabolites produced by fungi of the genus 
Aspergillus, majorly A. flavus and A. parasiticus. 
About 20 different types of AFs have been 
recognized. However, aflatoxin B1 (AFB1), 
aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), 
aflatoxin G2 (AFG2), aflatoxin M1 (AFM1) and 
aflatoxin M2 (AFM2) are of utmost toxicological 
importance [7]. AFs have a wide occurrence in 
different matrices. They have been reported in 
agricultural foods including cereals (rice, maize, 
sorghum, millet), cassava, nuts, oil seeds (such as 
sesame, sunflower), meat, eggs, dairy products, 
spices and animal feeds [8]. In foods and herbal 
products, they may occur before, during or after 
harvest, during storage or processing under 
conditions that favour the survival of the 
producing Aspergillus fungi [9-11].  
In our previous study [6], we concluded that 
various commodities in Uganda are 
contaminated with AFs, and most communities 
are exposed to acute chronic levels. Furthermore, 
we identified that herbal products, beers, barley 
and animal products (meat and blood) have been 
barely assessed in regard to these toxins. The aim 
of this study was therefore to quantify aflatoxins 
(AFB1, AFB2, AFG1 and AFG2) in Real Koff, 
Eddagala ly’e kifuba n’e senyiga, Omusujja, 
Cough mixture and Fever herbal products traded 
in Kampala city of Uganda and assess the 
probable human health risks from their 
consumption.  
Experimental part 
Materials and methods  
Aflatoxin (AFB1, AFG1, AFB2 and AFG2) 
standards  were procured from Sigma (St. Louis, 
MO, USA). Ethanol, methanol, and acetonitrile 
were from Sigma (Sigma-Aldrich, Steinheim, 
Germany). All other reagents used were of 
analytical grade, supplied by Merck (Darmstadt, 
Germany) and Sigma (St. Louis, MO, USA). 
Sample collection and preparation 
Liquid dosage forms of five common herbal 
medicines in their original packaging were each 
obtained from 15 popular herbal shops in 
Kampala, Uganda on 15th December 2019 
(Table 1; Figure 1). Kampala was chosen 
because of the big market and high sale turnover 
of herbal medicines [12]. Selection of these 
herbal formulations was also based on their 
availability and affordability by the public 
following a pilot survey. Samples were analyzed 
at Directorate of Government Analytical 
Laboratory, Wandegeya, Kampala, Uganda. 
Table 1.  Liquid herbal medicines sampled from Kampala, 
Uganda. 
ID Trade name 
Ailment(s) claimed to 
treat 
SL1 Real Koff product Cough and flu 
SL2 
Eddagala ly’e kifuba 
n’e senyiga 
Cough and flu 
SL3 Omusujja Various ailments 
SL4 Cough mixture 
Cough, asthma, 
fever, ulcers, measles 
SL5 Fever Fever 












Figure 1. One set of the sampled herbal medicines in their 
original packaging (left to right: Real Koff product, Eddagala 
ly’e kifuba n’e senyiga, Omusujja, Cough mixture and 
Fever). 
Aflatoxin analysis  
The working standards for AFs: 125 μL for AFB1 
and AFG1, 450 μL for AFB2 and AFG2 were 
diluted to 5 mL with acetonitrile/water (50: 50 
v/v) resulting in an intermediate mixed solution 
of 0.05 μg/mL for AFB1 and AFG1, 0.047 μg/mL 
and 0.045 μg/mL for AFB2 and AFG2, 
respectively. 
Aliquots (30 ml) of each sample were extracted 
using 10 ml acetonitrile-water (84: 16 v/v) for 30 
minutes with shaking at room temperature at 126 
rpm. They were then centrifuged for 5 minutes at 
3000 × g. Solid phase extraction was done and 
0.4 ml of the extracts were diluted with 0.6 ml of 
ammonium formate in water.  
Determination of aflatoxin levels in the sample 
extracts was performed by isocratic reversed-
phase high performance liquid chromatography-
tandem mass spectrometry with a MS/MS 
detector from Agilent Technologies (6400 Series 
Triple Quadrupole B.08.00, B8023.0). The 
analyses used binary gradient elution with 
solvent A (a mixture of 0.1% formic acid in water 
and 0.1% ammonium formate in water) while 
solvent B was made of 0.1% formic acid in 
methanol [13]. The total run time was 7 minutes.  
Sample solutions of 5 μL were injected into C-18 
reverse phase column (Poroshell 120 EC-C18 3 
× 50 mm, 2.7 µm, USA). Data acquisition 
software was for 6400 Series Triple Quadrupole, 
version B.08.00 while qualitative analysis 
software used was version B.07.00 Service Pack 
1. The flow rate was set at 0.3 mL/min and the 
column temperature maintained at 40.01 oC. The 
ionization source of the MS/MS detector had 4.0 
kV capillary voltage, 350 oC source temperature 
and 10 mL/min desolvation  gas flow using 
nitrogen gas (Supplementary File 1. Table 
S1)[13].  
The concentration of each aflatoxin in the 
samples were separately calculated by using the 
individual calibration curves obtained from the 
peak heights of each aflatoxin standard. 
Standards and samples were analyzed with a 
method detection limit of 0.03 µg/kg.  
Quality control was achieved through triplicate 
analysis of samples.  
Human health risk assessment  
The estimated daily intake (EDI) for ingestion of 
the herbal medicines as well as the hazard index 
(HI) were computed for both children 
(representing a sensitive group) and adults 
(representing the general population) to 
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approximate probable exposure through intake of 
herbal medicines. This was because traders 
reiterated that most people believed in the herbal 
products and take them daily, some along with 
their children, as a measure of preventing the 
ailments. 
The EDI was calculated using the mean levels of  
total aflatoxins obtained in the herbal medicines, 
the daily herbal intake of 0.25 L/day and 0.75 
L/day for Ugandan children and adults 
respectively [14] and the mean body weights of 
11.3 kg and 72.3 kg/person for children and 
adults respectively [15-17]. The EDI expressed 
in ng/kg of the body-weight/day (ng/kg bw/day) 
was calculated using Equation 1 [17-19]. 
EDI =  
     ×      
    
     (1) 
Where daily intake of herbal medicine is in L/day, mean 
level of aflatoxins in ng/kg and average body weight in kg.  
The hazard index was determined by dividing the 
EDI by TD50 (the daily dose in ng/kg/bw/day at 
which 50% of test animals would have developed 
tumours), divided by a safety factor of 50,000 as 
described by previous authors [17, 19-21]. TD50 
is the dose (mg/kg/bw/day) required to induce 
tumors in half of the test animals that would have 
remained tumor-free at zero dose. The complete 
mathematical relation of these parameters is 
given in Equation 2.  
     HI =  ∑   /   
,
                                             (2) 
 
Statistical analysis 
All quantitative data, unless otherwise 
stated, were presented as means with errors 
represented by standard deviations attached. The 
analyses were done using Minitab statistical 
software (v17, Minitab Inc., USA). The aflatoxin 
content of the samples was compared with the 
acceptable levels of aflatoxins in herbal products 
recommended by World Health Organization, 
European and United States pharmacopeias.   
Results and Discussion 
Aflatoxin content of the herbal medicines 
The current study evaluated the aflatoxin content 
of some herbal products sold in Kampala 
(Uganda) using a combination of high-
performance liquid chromatography and liquid 
chromatography-tandem quadrupole mass 
spectrometry. Despite the existence of several 
methods described for the determination of AFs 
in matrices [7], none of them can be applied to all 
matrices. In the case of natural products, the 
difficulty stems from the chemical complexity of 
different compounds in medicinal plants [22]. 
However, high-performance liquid 
chromatography-tandem quadrupole mass 
spectrometry (HPLC-MS/MS) has been reported 
and validated to determine the presence of AFs 
more accurately than HPLC and avoids the 
tedious derivatization process [23]. This method 
overcomes the drawbacks of HPLC by using 
tandem MS/MS detection, and is regarded as a 
confirmatory method for quick determination of 
AFB1, AFB2, AFG1 and AFG2 [23]. In this study, 
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we did not revalidate this method as it was 
already validated in-house by the same 
laboratory which handles at least 50% of samples 
requiring AFs analyses from most parts of the 
country.    
The aflatoxin content of the herbal products are 
given in Table 2. AFB1 was detected in 60% 
(3/5) of the herbal products: Real Koff product, 
Omusujja and Fever with mean AFB1 levels of 
6.83 ± 0.04, 6.38 ± 0.03 and 4.97 ± 0.07 µg/kg, 
respectively. Real Koff product and Omusujja 
had AFB1 in levels above WHO guideline, 
European pharmacopoeia as well as United 
States pharmacopoeia of ≤5, ≤2 and ≤5 µg/kg, 
respectively. In a previous study, Odda et al. [11] 
reported that the shoot powder of Phyllanthus 
amarus (Schum. and Thonn) from Tororo 
(Uganda) were contaminated with AFs in levels 
above the recommended limits for total AFs by 
WHO. In the current study, it was found that 
among the four AFs, AFB1 was detected as the 
most common and only contaminant. This is in 
consonance with previous reports [22-24] in 
which AFB1 was the dominant contaminant. This 
is usually because A. flavus which produces 
AFB1 and AFB2 is a very common fungus which 
infect plants. Conversely, AFG1 and AFG2 are 
less often detected in plant products because the 
producing fungus (A. parasiticus) does not infect 
plants very often [23, 25, 26]. This may account 
for the high incidence and concentrations of 
AFB1 compared with AFG1 and AFG2 in the 
herbal products investigated in this study. In 
addition, the total absence of other AFs in herbal 
products have been reported before [23, 27, 28].  
 Table 2. Aflatoxin content of the sampled herbal 
medicines from Kampala, Uganda. 
 
*BDL: Below method detection limit, **NA: Not 
applicable, NE: No established limit. 
       A plausible explanation for this observation 
could be due to the absence of the toxigenic fungi 
in the samples, the phytochemicals present in the 
products [29, 30] or environmental conditions 
during harvest and storage that did not favour 
biosynthesis of the other AFs. It is documented 
that temperature and water activity are the main 
factors that influence fungal invasion and the 
production of AFs in stored products. For 
example, Kulshrestha et al. [31] earlier reported 
that with a water activity below 0.81, 
temperatures of 25 ± 2 ℃, 30 ± 2 ℃, and 40 ± 2 
℃, and water activity over 0.81 and temperature 
below 10 ± 2 ℃, AFs were not detected in 
medicinal products that contained A. flavus (an 
aflatoxin producer). Similar results were later 
reported in Italy with no AFs detected in 48 
infusions and medicinal plants analyzed [28]. 
Sample ID 
Aflatoxin concentration (µg/kg) 
AFB1 AFB2 AFG1 AFG2 
Total 
AFs 
SL1 6.83 ± 0.04 BDL BDL BDL 6.83 
SL2 BDL* BDL BDL BDL NA 
SL3 6.38 ± 0.03 BDL BDL BDL 6.38 
SL4 BDL BDL BDL BDL NA 
SL5 4.97 ± 0.07 BDL BDL BDL 4.97 
WHO 
guideline 
≤5 NE NE NE NE 
European 
pharmacopeia 
≤ 2 NE NE NE NE 
US 
pharmacopeia 
≤5 NE NE NE NE 
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Though 40% and 10% of the samples had 
undetectable and allowable aflatoxin levels in 
herbal products, it should be noted that low level 
intake of AFs over long periods result in chronic 
aflatoxicosis expressed as impaired food 
conversion, stunting in children, 
immunosuppression, cancer and reduced life 
expectancy [32-35].  
 Human exposure assessment 
The estimated daily intakes of the herbal 
medicines ranged from 5.61 × 10-2 μg/kg/bw/day 
to 1.51 × 10-1 μg/kg/bw/day for both Ugandan 
children and adults (Table 3).  
Table 3. Human health risk assessment for Ugandans via 
intake of the herbal medicines. 
         The recorded hazard indices were in the 
range of 7.93 × 10-7 to 2.32 × 10-6.  Hazard 
indices less than or equal to 1 indicates no 
significant health risk but the possibility of long-
term adverse health effects increases with 
increasing hazard index. Hazard index between 
1.1 and 10 reflects a moderate risk while  hazard 
index greater than 10 indicates high risk [17]. 
The computed hazard indices were all less than 
1, implying that daily consumption of the 
individual herbal products may not pose health 
risks. However, the risk is higher in children. 
This is due to their higher dietary exposure per 
kg body weight and the differences in their body 
physiology when compared to adults [36].  The 
risks may also be amplified if two or more of the 
herbal products are consumed in tandem. 
Conclusions 
In the current study, we found that three 
out of the five commonly used herbal medicines 
in Kampala, Uganda were contaminated with 
aflatoxin B1, a potent carcinogen. Thus, 
Ugandans who heavily rely on herbal products 
could be exposed to aflatoxins at sublethal doses, 
which could have long term carcinogenic effects. 
We recommend further studies using a large 
sample size and in other parts of Uganda. The 
mycoflora associated with the contamination as 
well as co-ocurrence of aflatoxins with other 
mycotoxins in Ugandan herbal products should 
be investigated.   
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